Aarti Drugs Ltd vs Novelix Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Aarti Drugs Ltd is ₹ 380.7 as of 04 May 10:16 . The P/E Ratio of Aarti Drugs Ltd changed from 23.1 on March 2021 to 18.5 on March 2025 . This represents a CAGR of -4.34% over 5 yearsThe P/E Ratio of Novelix Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Aarti Drugs Ltd changed from ₹ 6475 crore on March 2021 to ₹ 3123 crore on March 2025 . This represents a CAGR of -13.57% over 5 yearsThe Market Cap of Novelix Pharmaceuticals Ltd changed from ₹ 5.48 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 years The revenue of Aarti Drugs Ltd for the Dec '25 is ₹ 602.94 crore as compare to the Sep '25 revenue of ₹ 652.88 crore. This represent the decline of -7.65% The revenue of Novelix Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Aarti Drugs Ltd for the Dec '25 is ₹ 56.26 crore as compare to the Sep '25 ebitda of ₹ 84.37 crore. This represent the decline of -33.32% The ebitda of Novelix Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Aarti Drugs Ltd changed from ₹ 33.27 crore to ₹ 40.55 crore over 7 quarters. This represents a CAGR of 11.97% The net profit of Novelix Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Aarti Drugs Ltd changed from 9.04 % on March 2021 to 5.8 % on March 2025 . This represents a CAGR of -8.49% over 5 yearsThe Dividend Payout of Novelix Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Aarti Drugs Ltd

Aarti Drugs Limited (ADL), incorporated in September, 1984 is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals.
The Company operates as part of the Aarti Group, a conglomerate with a net worth of USD 900 million.
With over 50 compounds for Antibiotics, Anti Protozoal, Anti-Inflammatory, Anti-diabetic, Anti Fungal and Cardioprotectant therapeutic segments, the Company has emerged as market leader in APIs.
Company also operates Pinnacle Life Science Private Limited, its wholly owned subsidiary focused on formulation development. The Company has two R&D divisions, one in Tarapur and the other in Turbhe, Maharashtra.
It has 3 subsidiaries, namely, Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SpA (foreign subsidiary).

About Novelix Pharmaceuticals Ltd

Trimurthi Limited was formerly incorporated on December 13, 1994 with the name Trimurthi Securities Ltd. The name of the Company thereafter got changed from Trimurthi Securities Ltd to Trimurthi Drugs & Pharmaceuticals Ltd. In September 2006, as per the Scheme of Arrangement, the erstwhile Trimurthi Drugs & Pharmaceuticals Ltd amalgamated with the Company.
Also, the name of the Company was changed to Trimurthi Drugs & Pharmaceuticals Ltd and again to Trimurthi Limited in May, 2016. Initially, the company was engaged in finance and investments in securities.
They ceased their operations due to the high volatility in the markets and voluntarily got de-registered as Non-Banking financial company.
Thereafter, the company explored the possibilities of entering into pharmaceutical and drug industry by way of diversification.

FAQs for the comparison of Aarti Drugs Ltd and Novelix Pharmaceuticals Ltd

Which company has a larger market capitalization, Aarti Drugs Ltd or Novelix Pharmaceuticals Ltd?

Market cap of Aarti Drugs Ltd is 3,423 Cr while Market cap of Novelix Pharmaceuticals Ltd is 58 Cr

What are the key factors driving the stock performance of Aarti Drugs Ltd and Novelix Pharmaceuticals Ltd?

The stock performance of Aarti Drugs Ltd and Novelix Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aarti Drugs Ltd and Novelix Pharmaceuticals Ltd?

As of May 4, 2026, the Aarti Drugs Ltd stock price is INR ₹375.05. On the other hand, Novelix Pharmaceuticals Ltd stock price is INR ₹40.5.

How do dividend payouts of Aarti Drugs Ltd and Novelix Pharmaceuticals Ltd compare?

To compare the dividend payouts of Aarti Drugs Ltd and Novelix Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.